-transparent.png){kind=logo}
Alternative splicing of cyclin D1 gene mRNA has recently been demonstrated. The novel transcript shows no splicing at the downstream exon 4 boundary and encodes a protein with an altered carboxyl-terminal domain that is a cyclin D1 variant; exon 5 is not included in the coding sequence which terminates downstream of exon 4. We here produced cells that exogenously express each form of cyclin D1 and analysed their cell cycle regulation. We found that (1) alternative splicing forms of cyclin D1 modulated entry into the cell cycle in an inverse manner; (2) both splicing forms suppressed cell growth; and (3) cells overexpressing form [a] were inhibited from entry into and completion of the S phase, although form [b]-expressing cells showed no reduction of G1- to S transition. We also found that overexpression of either cyclin D1 form upregulated Rb gene products, suggesting that this upregulation may be one of the causes of growth suppression in cyclin D1 overexpressing cells.
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
November 2003,
Cancer research,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
May 2004,
Developmental cell,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
August 1996,
Oncogene,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
September 1998,
Molecular and cellular biology,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
July 2011,
Proceedings of the National Academy of Sciences of the United States of America,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
October 1999,
Current biology : CB,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
April 2006,
Oncogene,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
August 2012,
Gene,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
October 2003,
Drug discovery today,
H Sawa, and
T A Ohshima, and
H Ukita, and
H Murakami, and
Y Chiba, and
H Kamada, and
M Hara, and
I Saito
January 2016,
PloS one,
